ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 78 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $0 | -100.0% | 400 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | -50.0% | 400 | 0.0% | 0.00% | – |
| Q2 2019 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q1 2019 | $2,000 | 0.0% | 400 | 0.0% | 0.00% | – |
| Q4 2018 | $2,000 | -99.1% | 400 | -97.6% | 0.00% | -100.0% |
| Q3 2018 | $225,000 | +21.0% | 16,609 | +5.5% | 0.00% | -33.3% |
| Q2 2018 | $186,000 | +1966.7% | 15,742 | +1867.8% | 0.00% | – |
| Q1 2018 | $9,000 | +80.0% | 800 | 0.0% | 0.00% | – |
| Q4 2017 | $5,000 | -28.6% | 800 | 0.0% | 0.00% | – |
| Q3 2017 | $7,000 | – | 800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 1,377,294 | $1,501,250 | 2.44% |
| NEA Management Company, LLC | 17,079,779 | $18,616,958 | 1.29% |
| Endurant Capital Management LP | 1,660,835 | $1,810,310 | 0.93% |
| Matrix Capital Management Company, LP | 38,974,185 | $42,481,862 | 0.58% |
| Long Focus Capital Management, LLC | 5,435,439 | $5,924,629 | 0.34% |
| PFM Health Sciences, LP | 5,992,571 | $6,531,902 | 0.29% |
| Key Client Fiduciary Advisors, LLC | 321,155 | $350,059 | 0.22% |
| DAFNA Capital Management LLC | 351,064 | $382,660 | 0.12% |
| Rock Springs Capital Management LP | 2,787,845 | $3,038,751 | 0.07% |
| Baker Brothers Advisors | 9,830,877 | $10,715,656 | 0.06% |